CES1 and allergic disease: Therapeutic efficacy and molecular mechanisms of the admixed vaccine (liposome-entrapped TGH + Per a 9) in causing mitigation of the allergic manifestations in the mouse model of CR allergy, was investigated in comparison with the liposome-entrapped-Per a 9 alone, liposome-entrapped-TGH alone, and placebo (liposome-entrapped-buffer).